Could angiotensin-converting enzyme 1 I/D polymorphism be a modificator of COVID-19 response in different populations, diseases, and/or conditions?
Open Access
- 1 July 2020
- journal article
- letter
- Published by Hindawi Limited in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 21 (3)
- https://doi.org/10.1177/1470320320957157
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- No significant correlation between ACE Ins/Del genetic polymorphism and COVID-19 infectioncclm, 2020
- COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-Chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?International Journal of Molecular Sciences, 2020
- ACE Ins/Del genetic polymorphism and epidemiological findings in COVID-19cclm, 2020
- Gender differences in patients with COVID-19: a narrative reviewMonaldi Archives for Chest Disease, 2020
- COVID-19 infections are also affected by human ACE1 D/I polymorphismcclm, 2020
- Angiotensin-converting enzyme insertion/deletion gene polymorphism and interferon-β treatment response in multiple sclerosis patientsPharmacogenetics and Genomics, 2017
- Angiotensin-converting enzyme gene insertion/deletion polymorphism is not associated with schizophrenia in a Croatian populationPsychiatric Genetics, 2012
- Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism in Lung Cancer PatientsGenetic Testing and Molecular Biomarkers, 2012
- Angiotensin-converting enzyme deletion allele is beneficial for the longevity of EuropeansAGE, 2011
- Angiotensin-converting enzyme I/D gene polymorphism and risk of multiple sclerosisActa Neurologica Scandinavica, 2006